What clobetasol propionate ointment concentrations are commercially available in the United States?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 29, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Clobetasol Propionate Ointment Concentration

Clobetasol propionate ointment is commercially available in the United States exclusively at a 0.05% concentration 1.

Available Formulations and Packaging

The FDA-approved clobetasol propionate ointment USP 0.05% is supplied in tamper-evident tubes in the following sizes 1:

  • 15 g (NDC 0168-0162-15)
  • 30 g (NDC 0168-0162-30)
  • 45 g (NDC 0168-0162-46)
  • 60 g (NDC 0168-0162-60)

Clinical Context

While the AAD-NPF guidelines list clobetasol propionate 0.05% as a Class I (superpotent) topical corticosteroid for psoriasis management 2, only the 0.05% concentration is FDA-approved and commercially available in ointment form in the United States. This concentration applies across all vehicle formulations (ointment, cream, gel, spray, foam, lotion, and shampoo) 1, 3.

Important Clinical Caveat

Although research has explored lower concentrations (such as 0.025% cream formulations studied in India) 4, these are not commercially available in the United States. Any prescriptions for clobetasol propionate ointment will be dispensed at the standard 0.05% concentration.

Storage Requirements

Store at controlled room temperature 15°-30°C (59°-86°F). Do not refrigerate 1.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.